Why the study?
Repeated blood pressure measurements allow better hypertension control, but current methods rely on cuff-based devices.
Does a novel cuff-less photoplethysmography-based device provide accurate and reliable blood pressure measurements compared to a standard sphygmomanometer in the general population?
Does a novel cuff-less photoplethysmography-based device provide accurate and reliable blood pressure measurements compared to a standard sphygmomanometer in the general population?
Answers are grounded in this paper and cite their sources.
A novel cuffless photoplethysmography-based device demonstrated high accuracy and reliability compared to standard sphygmomanometry, meeting ISO standards for blood pressure measurement.
Repeated blood pressure (BP) measurements allow better control of hypertension. Current measurements rely on cuff-based devices. The aim of the present study was to compare BP measurements using a novel cuff-less photoplethysmography-based device to a standard sphygmomanometer device. Males and females were recruited from within the general population who arrived at a public BP screening station. One to two measurements were taken from each using a sphygmomanometer-based and the photoplethysmography-based devices. Devices were considered equal if the mean difference between paired measurements was below 5 mmHg and the Standard Deviation (SD) was no greater than 8 mmHg. Agreement and reliability analyses were also performed. 1057 subjects were included in the study analysis. There were no adverse events during the study. The mean (± SD) difference between paired measurements for all subjects was -0.1 ± 3.6 mmHg for the systolic and 0.0 ± 3.5 mmHg for the diastolic readings. We found 96.31% agreement in identifying hypertension and an Interclass Correlation Coefficient of 0.99 and 0.97 for systolic and diastolic measurements, respectively. The photoplethysmography-based device was found similar to the gold-standard sphygmomanometer-based device with high agreement and reliability levels. The device might enable a reliable, more convenient method for repeated BP monitoring.
No takes yet. Share an insight, caveat, or question.
Nachman et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: